Cambridge, MA – Bicycle Therapeutics plc has announced the appointment of Michael Skynner as Chief Technology Officer. About Bicycle Therapeutics plc: Bicycle Therapeutics (NASDAQ: BCYC) is a biotechnology company focused on developing precision-guided therapeutics, primarily targeting solid tumor cancers. The company aims to become a leading solid tumor medicines company, measured by its pipeline’s potential and the number of patients it can treat. Bicycle Therapeutics utilizes its unique Bicycle molecule technology to penetrate deep into tissues and target intractable cancers, with a clear mission to create impactful medicines that transform patient lives. Beyond oncology, the company is exploring other therapeutic applications through collaborations with pharma partners and academic leaders in areas such as anti-infectives, cardiovascular, ophthalmology, and neurological disorders.

For more information on Bicycle Therapeutics plc please visit: https://www.bicycletherapeutics.com/

Bicycle Therapeutics plc
35 Cambridgepark Dr Suite 350
Cambridge, MA 2140
Phone: 617-945-8155
LinkedIn Page: https://www.linkedin.com/company/bicycle-therapeutics/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved